The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia

Hyperuricemia (HU) often progresses to combine with non-alcoholic fatty liver disease (NAFLD) in the clinical scenario, which further exacerbates metabolic disorders; early detection of biomarkers, if obtained during the HU progression, may be beneficial for preventing its combination with NAFLD. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Yong, Liu, Xinru, Zhou, Ke, He, Xiaojuan, Lu, Cheng, He, Bing, Niu, Xuyan, Xiao, Cheng, Xu, Gang, Bian, Zhaoxiang, Zu, Xianpeng, Zhang, Ge, Zhang, Weidong, Lu, Aiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758628/
https://www.ncbi.nlm.nih.gov/pubmed/26890003
http://dx.doi.org/10.1371/journal.pone.0149043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758628/
https://www.ncbi.nlm.nih.gov/pubmed/26890003
http://dx.doi.org/10.1371/journal.pone.0149043

Ejemplares similares